127 related articles for article (PubMed ID: 15265916)
41. The IgH locus 3' cis-regulatory super-enhancer co-opts AID for allelic transvection.
Le Noir S; Laffleur B; Carrion C; Garot A; Lecardeur S; Pinaud E; Denizot Y; Skok J; Cogné M
Oncotarget; 2017 Feb; 8(8):12929-12940. PubMed ID: 28088785
[TBL] [Abstract][Full Text] [Related]
42. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
Hengstschläger M; Williams M; Maizels N
Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
[TBL] [Abstract][Full Text] [Related]
43. Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation.
Kuzin II; Bagaeva L; Young FM; Bottaro A
J Immunol; 2008 Jun; 180(11):7443-50. PubMed ID: 18490744
[TBL] [Abstract][Full Text] [Related]
44. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
[TBL] [Abstract][Full Text] [Related]
45. V(D)J recombination and allelic exclusion of a TCR beta-chain minilocus occurs in the absence of a functional promoter.
Alvarez JD; Anderson SJ; Loh DY
J Immunol; 1995 Aug; 155(3):1191-202. PubMed ID: 7636187
[TBL] [Abstract][Full Text] [Related]
46. Sequence analysis of human IgVH genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches.
Dunn-Walters DK; Isaacson PG; Spencer J
Eur J Immunol; 1997 Feb; 27(2):463-7. PubMed ID: 9045918
[TBL] [Abstract][Full Text] [Related]
47. The transcription factor Spi-B is not required for somatic hypermutation.
Kim N; Martin TE; Simon MC; Storb U
Mol Immunol; 2003 Jan; 39(10):577-83. PubMed ID: 12431391
[TBL] [Abstract][Full Text] [Related]
48. Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production.
Lutz J; Heideman MR; Roth E; van den Berk P; Müller W; Raman C; Wabl M; Jacobs H; Jäck HM
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10644-9. PubMed ID: 21670279
[TBL] [Abstract][Full Text] [Related]
49. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.
Kong Q; Zhao L; Subbaiah S; Maizels N
J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236
[TBL] [Abstract][Full Text] [Related]
50. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
Roes J; Hüppi K; Rajewsky K; Sablitzky F
J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
[TBL] [Abstract][Full Text] [Related]
51. Sequential activation and distinct functions for distal and proximal modules within the IgH 3' regulatory region.
Garot A; Marquet M; Saintamand A; Bender S; Le Noir S; Rouaud P; Carrion C; Oruc Z; Bébin AG; Moreau J; Lebrigand K; Denizot Y; Alt FW; Cogné M; Pinaud E
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1618-23. PubMed ID: 26831080
[TBL] [Abstract][Full Text] [Related]
52. Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes.
González-Fernández A; Milstein C
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9862-6. PubMed ID: 8234326
[TBL] [Abstract][Full Text] [Related]
53. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
Lin MM; Green NS; Zhang W; Scharff MD
Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
[TBL] [Abstract][Full Text] [Related]
54. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
55. Elucidation of IgH intronic enhancer functions via germ-line deletion.
Perlot T; Alt FW; Bassing CH; Suh H; Pinaud E
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14362-7. PubMed ID: 16186486
[TBL] [Abstract][Full Text] [Related]
56. Dual enigma of somatic hypermutation of immunoglobulin variable genes: targeting and mechanism.
Winter DB; Gearhart PJ
Immunol Rev; 1998 Apr; 162():89-96. PubMed ID: 9602355
[TBL] [Abstract][Full Text] [Related]
57. VH replacement rescues progenitor B cells with two nonproductive VDJ alleles.
Lutz J; Müller W; Jäck HM
J Immunol; 2006 Nov; 177(10):7007-14. PubMed ID: 17082616
[TBL] [Abstract][Full Text] [Related]
58. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
59. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
Schlissel MS; Morrow T
J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
[TBL] [Abstract][Full Text] [Related]
60. IgVH gene analysis suggests that peritoneal B cells do not contribute to the gut immune system in man.
Boursier L; Farstad IN; Mellembakken JR; Brandtzaeg P; Spencer J
Eur J Immunol; 2002 Sep; 32(9):2427-36. PubMed ID: 12207327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
